Skip to the page

Data / Form D filings / Bobo Labs Inc

Bobo Labs Inc: Form D filing

Bobo Labs Inc, a health care company in Yardlsley, PA, filed a Form D with the SEC in 2025. The latest, on February 11, 2025, reports $250,000 sold of a $6 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
913 N Pennsylvania Av, Yardlsley, PA, 10967
Phone
(212) 907-7370
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2021
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2055372

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Feb 11, 2025New notice$6,000,000$250,000$5,750,0001Jan 13, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Turner Fernand NovakDirector
Benedicte Fernand LeMarieDirector
Walid Fernand AbboudDirector
Ludmilla Fernand Le MarieDirector
Kethleen Fernand WidmerExecutive Officer, Director
Felipe Fernand JimenezDirector
Edouard Fernand LeMarieDirector
Michael Fernand McNamaraDirector
Barry Fernand BrunoExecutive Officer, Director
Lawrence Fernand BellDirector

Other health care companies in Pennsylvania that filed recently

Every Form D from the week of Feb 10, 2025 · All recent filings in Pennsylvania · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Bobo Labs Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.